The dual-isotope ProstaScint imaging procedure: Clinical experience and staging results in 145 patients

Clinical Nuclear Medicine

Volumn 25, Issue 1, 2000, Pages 33-40

  Quintana, Juan Carlos ^a,b   Blend, Michael J ^a,c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

Dual Isotope Tumor Imaging; ProstaScint Imaging; Prostate Cancer Staging

Indexed keywords

CAPROMAB PENDETIDE IN 111; ERYTHROCYTE TC 99M; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER PROGRAM; CONTROLLED STUDY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PELVIS LYMPH NODE; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

ANTIBODIES, MONOCLONAL; FOLLOW-UP STUDIES; HUMANS; INDIUM RADIOISOTOPES; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033982180     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200001000-00008     Document Type: Article

References (29)

1. Cancer Facts and Figures, 1997. Atlanta, GA: American Cancer Society, 1997.
2. Murphy GP, Natarajan N, Pontes JE, et al: The National survey of prostate cancer in the United States by the American College of Surgeons. J Urol 127:928, 1982.
3. Crawford ED: T3 prostate cancer: Defining the challenge. Urol Clinics 1:5, 1998.
4. Scardino PT: Early detection of prostate cancer. Urol Clin North Am 126:635, 1989.
5. Okada K, Yoshidn O, Paulson DF, Rutlshauser G: Lymph node staging in potentially curable prostatic carcinoma. EORTC Genitourinary Group Monograph 5:221, 1988.
6. Tempany CM, Zhou S, Zerhoui EA, et al: Staging of prostate cancer: Results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 192:47, 1994.
7. Haseman MK, Reed NL, Rosenthal SA: Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Clin Nucl Med 21:704, 1996.
8. Kuban DA, El-Mahdi AM, Schellhammer PF: Prostate specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiation Oncol Biol Phys 32:307, 1995.
9. Hamper UM, Sheth S, Walsh PC, Holtz PM, Epstein JI: Capsular transgression of prostatic carcinoma: Evaluation with transrectal US with pathologic correlation. Radiology 178:791, 1991.
10. McSherry SA, Levy F, Schiebler ML, et al: Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: Comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. J Urol 146:85, 1991.
11. Kramer S, Gurich J, Gottfried HW, et al: Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy. Br J Urol 70:995, 1997.
12. Rifkin MD, Zerhouni EA, Gatsonis CA, et al: Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. N Engl J Med 323:621, 1990.
13. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM: Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 150:391, 1993.
14. Fowler JE, Brooks J, Pandey P, Seaver LE: Variable histology of anastomotic biopsies with detectable prostate specific antigen after radical prostatectomy. J Urol 153:1011, 1995.
15. Babaian RJ, Lamki LM: Radioimmunoscintigraphy of prostate cancer. Semin Nucl Med 19:309, 1989.
16. Maguire RT, Pascucci VL, Maroli AN, Gulfo JV: Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Cancer 72(Suppl):3453, 1993.
17. Kahn D, Williams RD, Seldin DW, et al: Radioimmunoscintigraphy with In-111 labeled CYT-356 for the detection of occult prostate cancer recurrence. J Urol 152:1490, 1994.
18. Babaian RJ, Sayer J, Podoloff DA, et al: Radioimmunoscintigraphy of pelvic lymph nodes with In-111-labeled monoclonal antibody CYT-356. J Urol 152:1952, 1994.
19. Burgers JK, Hinkle GH, Haseman MK: Monoclonal antibody imaging of recurrent and metastatic prostate cancer. Semin Urol 18:103, 1995.
20. Sychra JJ, Lin KQ, Blend MJ: Detection of metastatic prostate cancer with simultaneous dual radioisotope SPECT images. World Wide Web page: http://ej.rsna.org/ej2/EJ_0_96/0034-97, fin/prostate. accessed through the RSNA home page: http:// www.rsna.org. Oak Brook, IL: Radiological Society of North America, 1998.
21. Sychra JJ, Blend MJ: A computer program for analysis of simultaneously acquired dual isotope SPECT images in prostate cancer patients [Abstract 1306]. J Nucl Med 39:276, 1998.
22. UltraTag RBC package insert. St Louis: Mallinckrodt Medical, September 1992.
23. Varkarakis MJ, Murphy GP, Nelson CMK, et al: Lymph node involvement in prostatic carcinoma. Urol Clin North Am 2:197, 1975.
24. Hinkle GH, Burgers JK, Olsen JO, et al: Prostate cancer abdominal metastases detected with indium-111 capromab pendetide. J Nucl Med 39:650, 1998.
25. Saltoh H, Yoshida KJ, Uchjiima Y, et al: Two different lymph node metastatic patterns of prostatic cancer. Cancer 65:1843, 1990.
26. Polascik TJ, Gurganus RT, Partin AW, et al: Comparison of staging algorithms and a monoclonal antibody scan (Prosta-Scint) to predict lymph node involvement in high-risk prostate cancer [Abstract]. J Urol 159:289, 1998.
27. Kahn D, Williams RD, Manyak MJ, et al: ProstaScint Study Group: Indium-111 capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. J Urol 159:2041, 1998.
28. Levesque PE, Nieh FT, Zinman LN, Seldin DW, Libertino JA: Radiolabeled monoclonal antibody indium-111-labeled CYT-365 localizes extraprostatic recurrent carcinoma after prostatectomy. Urology 51:978, 1998.
29. Haseman MK, Reed NL: Capromab pendetide imaging of prostate cancer. In: Freeman LM, ed. Nuclear Medicine Annual 1998. Philadelphia: Lippincott-Raven Publishers, 1998, pp 51-82.